FIELD: chemistry.
SUBSTANCE: objective of the present invention is to obtain a compound of formula (I), having p-opioid receptor antagonist action, which causes less side effects, hence, is less safe, or a pharmacologically acceptable salt thereof, and preparing a medicinal agent for use in preventing or treating itch based on antagonistic action on μ-opioid receptors.
EFFECT: disclosed is new 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purposes.
15 cl, 7 tbl, 42 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOUNDS | 2018 |
|
RU2767857C2 |
PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
HEXONE-GLUCOKINASE INHIBITOR AND ITS USE | 2020 |
|
RU2797185C2 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2786722C1 |
AZABICYCLO{3,1,0}HEXANE DERIVATIVES USED AS DOPAMINE RECEPTOR D3 MODULATORS | 2005 |
|
RU2434011C2 |
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2022 |
|
RU2803084C1 |
AMINOPYRIDINE DERIVATIVES AND APPLICATION THEREOF AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2777979C2 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
THERAPEUTIC REMEDY FOR DISORDERS RELATED TO ALCOHOL CONSUMPTION | 2018 |
|
RU2761219C2 |
Authors
Dates
2019-10-02—Published
2014-11-19—Filed